创新药的牛股们

医曜
Sep 03, 2025

本文系基于公开资料撰写,仅作为信息交流之用,不构成任何投资建议。8月28日,半导体公司寒武纪大涨15.73%至1595.88元,超越贵州茅台成为A股股王。自此,贵州茅台为代表的“黄金时代”落幕,以寒武纪为首的科技力量全面崛起。这场科技牛市中,除耀眼夺目的芯片龙头寒武纪外,创新药亦是重要的助推力量。年初至今,股价翻倍的医药公司不在少数,这其中长期被低估的港股Biotech公司,更是诞生出众多的数倍股...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10